Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study.

Savage SJ, Ercole CE, Hemstreet G, Leone A, Masterson T, McWilliams G, Risk M, Schroeck FR, Stratton K, Lough T, de Lange M, Sakamoto K

Open source

DOI
10.1016/j.urolonc.2025.10.008
Published
2026 Jan
Container
Urologic oncology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.urolonc.2025.10.008,
  title = {Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study.},
  author = {Savage SJ and Ercole CE and Hemstreet G and Leone A and Masterson T and McWilliams G and Risk M and Schroeck FR and Stratton K and Lough T and de Lange M and Sakamoto K},
  year = {2026},
  journal = {Urologic oncology},
  doi = {10.1016/j.urolonc.2025.10.008},
  url = {https://doi.org/10.1016/j.urolonc.2025.10.008}
}

RIS

TY  - JOUR
TI  - Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study.
AU  - Savage SJ
AU  - Ercole CE
AU  - Hemstreet G
AU  - Leone A
AU  - Masterson T
AU  - McWilliams G
AU  - Risk M
AU  - Schroeck FR
AU  - Stratton K
AU  - Lough T
AU  - de Lange M
AU  - Sakamoto K
PY  - 2026
JO  - Urologic oncology
DO  - 10.1016/j.urolonc.2025.10.008
UR  - https://doi.org/10.1016/j.urolonc.2025.10.008
ER  - 

APA

SJ, S., CE, E., G, H., A, L., T, M., G, M., M, R., FR, S., K, S., T, L., M, D. L., & K, S. (2026). Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study.. Urologic oncology. https://doi.org/10.1016/j.urolonc.2025.10.008

Source records